Increased levels of NF-κB inhibitors (IκBα and IκBγ) in the intestinal mucosa of Crohn's disease patients during infliximab treatment, Guidi, L., Costanzo Mario, Ciarniello M., De Vitis I., Pioli Claudio, Gatta L., Pace L., Tricerri A., Bartoloni C., Coppola L., et al. , International Journal of Immunopathology and Pharmacology, Volume 18, Number 1, p.155-164, (2005)

Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IκBα degradation and RelA activation, Pioli, Claudio, Gatta L., Frasca D., and Doria G. , European Journal of Immunology, Volume 29, Number 3, p.856-863, (1999)